Skip to main content

Abstract

Objective:

The study examined lifetime use of mental health services among children diagnosed as having mental disorders in two major cities in Brazil and identified characteristics associated with unmet need.

Methods:

The data were collected as part of the High Risk Cohort Study, a community study conducted in Sao Paulo and Porto Alegre, Brazil. During the period from 2010 to 2011, a total of 2,511 children ages 6 to 12 were assessed, and 652 were given a diagnosis of at least one mental disorder. The current study analyzed data for a subsample of 651 children with complete information on use of mental health services.

Results:

Eighty-one percent of the children with mental disorders had not received mental health treatment in the past. The majority who received treatment were treated with psychotherapy or a combination of psychotherapy and medication. Mixed-race children were significantly more likely to have unmet need for treatment, compared with white children.

Conclusions:

The high rate of unmet need among children with mental disorders should be addressed with strategies to improve access to health care.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ps.201800389.ds001.pdf)

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: XXXX

Psychiatric Services
Pages: 337 - 341
PubMed: 30651056

History

Received: 20 August 2018
Revision received: 17 October 2018
Accepted: 26 November 2018
Published online: 17 January 2019
Published in print: April 01, 2019

Keywords

  1. Epidemiology
  2. Child psychiatry/general
  3. public health
  4. health services

Authors

Affiliations

Daniel Fatori, Ph.D. [email protected]
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Giovanni Abrahão Salum, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Luis Augusto Rohde, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Pedro Mario Pan, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Rodrigo Bressan, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Sara Evans-Lacko, Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Guilherme Polanczyk, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Euripedes Constantino Miguel, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).
Ana Soledade Graeff-Martins, M.D., Ph.D.
Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil (Fatori, Polanczyk, Miguel); Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil (Salum, Rohde, Graeff-Martins); Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil (Pan, Bressan); Personal Social Services Research Unit, London School of Economics and Political Science, London (Evans-Lacko).

Notes

Send correspondence to Dr. Fatori ([email protected]).

Funding Information

Dr. Rohde has been a member of the speakers bureau for, has been a consultant for, and has received unrestricted educational and research support from Eli-Lilly, Janssen-Cilag, Novartis, and Shire within the past 3 years. He has received authorship royalties from Oxford Press and ArtMed and has received travel awards from Shire for taking part in the 2014 American Psychiatric Association and 2015 World Federation of ADHD meetings. Dr. Polanczyk has received grant or research support from the National Council for Scientific and Technological Development, the São Paulo Research Foundation, Fundação Maria Cecilia Souto Vidigal, Grand Challenges Canada, and the Bill & Melinda Gates Foundation. He has served as a consultant to Shire and Johnson & Johnson and has been a member of the speakers bureau of Shire. He has received royalties from Editora Manole. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share